First, one strategy using nanoparticular systems to overcome the MDR cancers is to formulate both anticancer agents and biological modification agents (such as P-gp inhibitors, ATP depletion molecules, and cell membrane modifiers) into nano-systems. Here, PGP is linked to cancer.